Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Salvia BioElectronics
Age
18–84
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of migraine as defined by the ICHD-3 Classification (with or without aura) with a history of chronic or high-frequency episodic migraine for at least 1 year prior to screening
Failure of 3 or more preventive pharmacological therapies
Stable on preventive migraine treatments
Psychologically stable
You may not be if
Concomitant invasive or non-invasive neuromodulation
Previous exposure to an implantable neuromodulation device for headache
Have an existing active implantable medical device nearby the implant location (e.g. DBS, cochlear implant)
Use of onabotulinum toxin A injections for the treatment of migraine in the past 3 months.
Use of local corticosteroid injections in the occipital or supra-orbital region in the past 3 months prior to enrollment.
